The following entities are covered by the Patient Research Council NCT West: malignant melanoma, multiple myeloma, rectal carcinoma, bile duct carcinoma, leukemia (in children), breast cancer, ovarian cancer, brain tumor (glioblastoma) and sarcoma.
Patient research councils are experienced patient representatives who have gained significant previous experience with advisory boards and assessing clinical studies and research projects.
The main areas of activity are:
- Supporting researchers in optimizing clinical trials and other projects at the NCT West;
- Working closely with the NCT West Board of Directors to advise on the further development of the site;
- Promoting cooperation with self-help organizations, physicians, scientists, and institutions at the NCT West site.
Mike Butler
Co-speaker Campus Cologne;
member of the CIO Cologne Patient Advisory Board
Dirk Hellrung
Co-speaker Campus Essen;
member of the DKFZ Cancer Research
Patient Advisory Board
Anne Fox
Campus Essen
Maximillian Heller
Campus Cologne;
member of the CIO Cologne Patient Advisory Board
Thorsten Hilgers
Campus Cologne;
member of the CIO Cologne Patient Advisory Board
Robert Marx
Campus Cologne
Nicola Prasuhn
Campus Essen;
member of the WTZ Patient Advisory Board
Eva Radermacher
Campus Cologne
Markus Wartenberg
Campus Essen;
spokesperson of the NCT Patient Research Council
